In ovarian cancer, FoxO3a interacted with a SMAD2/SMAD3/SMAD4 complex in the nucleus, which could maintain activated SMAD proteins at high levels, and this interaction in turn promoted the cell-cycle arrest synergistically [32,33]. Here, SMAD3 is linked to ovarian carcinoma.